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Bovine heart 6.phosphofructo-2-kinase/fructosL h-2b-bisphosphatasc (PFK-2/FBPase-2) was phosphorylated byincubation with [r-‘rP]MgATP and 
cyclic AMP-dependent protein kinasc (PKA) or protein kinasc C (PKC). After digestion with chymotrypsin, the phosphorylation sites for the two 
protein kinascs were identified by pcpddc mapping, and microsequencing. Evidence for new phosphorylation sites for PICA (Ser-483) and PKC 
(Ser.84 and Ser-466) was obtained. 
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1. INTRODUCTION 
The bifunctional enzyme 6-phosphofructo-2-kinase/ 
fructose-2,6_bisphosphatase (PFK-2/FBPase-2) cataly- 
ses the synthesis and degradatioil of fructose 2,6-bis- 
phcsphate (Fru-2,6-P2), which is an important regulator 
of glycolysis [1,2]. The liver (L-type) and heart (H-type) 
isozymcs, but not the muscle (M-type) isozyme, are sub- 
strates of the cyclic AMP-dependent protein kinase 
(PIW 131. 
Phosphorylation by PKA has different effects on the 
activities of the L- and H-type isozymes: phosphoryla- 
tion of the L-type leads to PFK-2 inactivation (increase 
in K”,fP for fructose 6-phosphate (Fru-6-P) and decrease 
in V,,,J and FBPase-2 activation (increase in V,,,,) [4,5], 
whereas phosphorylation of the H-type results in a 
small activation of PFK-2 (decrease in&fP for Fru-6-P) 
with no effect on FBPase-2 activity [6,7]. H-Type PFK- 
2/FBPase-2 is also a substrate of protein kinase C 
(PKC), but phosphorylation has no effect on its enzyme 
activities [7,8]. 
site for PKA lies in the N-terminal domain at Ser-32 [9], 
while for bovine heart PFK-2/FBPase-2 the phospho- 
rylation sites for PKA and PKC are in the C-terminal 
domain at Ser-466 and Thr-47S, respectively [lo]. Two 
forms of PFK-2/FBPase-2 have heen identified in bo- 
vine heart with subunit M,s of 58,000 and 54,000 
[6,7,11], wllich result from alternative splicing of the 
same primary transcript [7]. The 54,000 M, form of 
bovine heart PFK-UFBPase-2 differs from the 58,OW 
M, form in that it lacks a C-terminal peptide (residues 
451-510), which is encoded by exon 15 in the rat gene 
[12] and which contains the phosphorylation sites for 
PKA and PKC; however, since the SS,ooO JJr form is 
also phosphorylated by both PKA and PKC [7], phos- 
phorylation sites other than Ser-466 (WA) and Thr-475 
(PKC) should be present in this form. In this paper we 
present evidence for new phosphorylation sites for PKA 
and PKC in bovine heart PFK-2/FBPase-2. 
2. EXPERlMENTAL 
In rat liver PFK-YFBPase-2, the phosphorylation 
Correspum’ence acf&ess: M.H. Hider, ICP-UCL 7529, .4v. Hippocrate 
75, B-1260, Brussels, Belgium. Fax: (32) (2) 7G2 7455. 
Abbrcvilrrfons: FBPas-2, fructose-2,G-bisphosphatase (EC 3.1.3.46); 
F,u-B-P, frxtcse 6.pho @ate; Fru-2,6-Pi, fructose P,G-bisphosphute; 
PFK-2,6-phosphofructo-2-kinase (EC 2.7.1.105); PKA, cyclic AMP- 
dependent protein kinase (EC 2.7.1.37); PKC. protein kinase C (EC 
2.7.1.3-I); PTH, phenylthiohydantoin. 
Bovine heart PFK-2IFBPasc-2, PKA, nnd PKC were purified as 
described previously [7,8]. One unit of enzyme activity ia the amount 
which catalyses the formation of 1 ,umol of producbmin under the 
assay conditions. 
The bovine heart PFlGYFBPase-2 preparation (WOE(~) was incu- 
batrxi in a Rnal volumcof0.2 ml with 5OyM &-‘zP]MgATPand 1 mU 
of either PKA or PKC for 60 min as described in [7]. Proleins were 
precipitated by 10% (w/v) trichloroacetic acid and the mixture was 
allowed to stand in ice for 30 min. The precipitated proteins were 
coll~xtcd by ccntrifugation (5.000 rpm for 5 min in an Eppendorf 
microfugc), washed twice with I ml of ice-cold acetone and dissolved 
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in 0.2 ml oT 2 M urea, 100 mM NHJ-lCO,, pH 8.0. The 
phosphorylatcd proteins were then digested with 25,ugofchymotryp- 
sin for 4 h at 35°C. 
Peptides were first separated on a Vydae Cl 8 column (0.46 x 25 cm) 
cquilibraled in 0.1% (v/v) tritluoroacetic acid (solvent A) using the 
following gradient program: 5-1008 B in 100 min (where B = 0.1% 
(v/v) trifluoroacetic acid/70% (v/v) CM,CN) at a Row rtite of 1 mVmin. 
Fractions (1 ml) were collected and those containing radioactivity 
were lyophilised. Radiolabellcd peptides were dissolved in 200 ~1 of 
0.1% (v/v) trifluoroacetic acid and purified by narrowborc MPLC as 
described in [I], Where necessary, radiolabelled peptides were further 
purified by narrowbore MPLC in which the aqueous phase was IO m,M 
sodium phosphate, pH 6, and the organic phase was IO mM sodium 
phosphate, pH 6, 60% CH,CN 171. Purified radiolahelled peptides 
were sequenced using tm Applied Biosystems 477A pulsed liquid- 
phase sequcnator equipped with a 120A PTH analyser. 
Peptides, TKASLRISEK [13], KKCSWASYM [I31 and YRR- 
QAVKSYK [14], corresponding to residues 17-26, 2G-34 and 77-86 
of bovine heart PFK-YFBPase-2, were synthesized as described. The 
pcptides were phosphorylated with PICA and PKC as described in 
Table II. K”,fPvalucs werecalculated bynon-linear least squares fitting 
of the data to a hyperbola using a computer program [151. 
3. RESULTS AND DISCUSSION 
The purified preparation of bovine heart PFK-2/ 
FBPase-2, which contains a mixture of the 58,000 and 
54,000 M, forms, was phosphorylated from 
[y3’P]MgAT? by either PKC or IX4 and digested with 
chymotrypsin. Fig. I shows the elution profile of radio- 
activity obtained by MPLC separation of chymotryptic 
peptides. PKC treatment led to the labelling of three 
peaks (peaks I-III) while PKA treatment led to the 
labelling of two peaks (peaks IV and V). The labelled 
peaks were further purified by narrowbore MPLC using 
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Fig, 1. NPLC of cbymotryptic fragments of bovine heart PFK-2/ 
FBPasc-2 labclled with [y-“P]MgATP and either PKC or PKA. BO- 
vine heart PFK-2/FBPase-2 was incubated with [$?P]MgATP and 
either PKC (a) or PKA (b) for HPLC as described in section 2. 
Fractions (1 ml) were collected and aliquots (20 ~1) were counted for 
radioactivity. 
Table 1 
Amino acid sequences orphospholylated pcptides purified from bovine heart PFK&FBPase-2 incubated with [y-)‘P]MgATP and either PKC or 
PKA 
PKC 
Peak 
1 
ISIS 
II 
AS/S 
Amino acid sequ~xe of purified phosphorylated peptidc 
R(19.7), R(13.9), Q(31.1), A(37.9), V(33.6), K(19.3), S(l.7), Y(8.6) 
8.0 
X, S(4.4), S(3.2), N(8.G), X, 1(7.8), R(2.8), R(3.1), P(6.4), R(2.7), N(T.I), Y(l.8) 
1.2 1.6 
Position in bovine heart 
PFK-2/FBPasc-2 sequent 
78-85 
471-482 
PKA 
III 
AS/S 
IV 
ASis 
R(18 8), R(11.3), N(14.7), S(1.7). F(13.9),T(3.3), P(2.4), L(l.6) 
4.7 
R(2.9), R(3.3), N(12.0), S(O.5), F(19.9). T(T.O), P(5.7), L(3.2) 
14.0 
4G3-470 
463470 
V 
A!?& 
X, V(I5.9). G(22.0), S(4.1), R(4.4), P&.2), ~(3.4) 483-489 
2.0 
“P-Labelled peptides from peaks 1-V in Fig. I were purified as described for microsequencing. X represents a residue which could not be identified. 
ASIS represcnls the ratio of dehydroalanine/serine, calculated from the peak heights of their PTH derivatives. A low yield of PTM serinc and a 
high AS/S ratio is indicative of a phosphorylated serinc residue. FTH amino acid yields in pmol arc given in parentheses. 
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Phosphorylation of synthetic peptidcs corresponding to scqucnces of bovine heart PFK-2/FBPasc-2 by PKA and PKC 
Peptide sequence 
TKASLRISEK KKCSWASYM YRROAVKSYK 
Gp CuW PKA N.M. 640 N.M. 
PKC 810 2910 54 
Stoichiometry of phosphorylation (moVmol) PKA 0.06 0.73 0.01 
PKC t-I.73 0.20 0.35 
The synthetic peptides were phosphorylated as descrilxxl in [7]. For the measurements of Km , 0,2 mU of protein kinass was used and the 
concentration of pcpdde was varied from 0.01-5 mM. The stoichiometry ofpeptidc phosphorylation was measured with 5OyM peptide and 2 mU 
of protein kinasc. N.M., not measured 
a linear gradient of acetonitri!e as described in section 
2. Table I shows the sequences of the radiolabelled pep- 
tides from peaks I-V, For each peak of radioactivity in 
Fig. 1 a single labelled peptide was isolated. 
Table I shows that, as expected, PKC treatment led 
to the labelling of a peptide containing Thr-475, the 
phosphorylation site in the C-terminal domain de- 
scribed by Uyeda and co-workers [6,IO3. Thr-475 was 
not detected in the PTH analyser, because it was 
phosphorylated. PKC treatment also led to the labelling 
of a peptide whose sequence was RRN$FTPL contain- 
ing Ser-466 (Tabie I), the site previously shown to be 
phosphorylated by PKA [6,10]. 
In a previous tudy, we found that the 54,000 A4, form 
of bovine heart was phosphorylated by both PKA and 
PKC, suggesting the existence of other phoaphoryletion 
sites, and microsequencing revealed the three following 
peptides: 19-ASLR-22, SO-QAVKSYK-86 and 57- 
KLTR-GO, but the phosphorylation site could not be 
identified [7]. Our present results show that treatment 
of bovine heart PFK-YFBPase-2 with PKC led to the 
labelling of a chymotryptic peptide, 78-RRQAVKSY- 
85 (Table I), which overlaps with the sequence of the 
tryptic peptide, 80-QAVKSYK-86, previously de- 
scribed [7]. A synthetic peptide containing Ser-84 was 
phosphorylated by PKC with a low pzprp, whereas apep- 
tide with the sequence ASLR, containing Ser-20, which 
Fig. 2. Schematic representation of the phosphorylation sites in the 
two forms of bovine heart PFK-DFBPasc-2. 
was previously identified as a potential phosphorylation 
site for PKC [7], was a poor substrate (Table II). There- 
fore, Ser-84 is the phosphorylation site for PKC in the 
54,000 M, form (Fig. 2). 
PKA treatment of bovine heart PFK-2/FBPase-2 led 
to the labelling of two peptides (Table I), one of which 
contained Ser-466, the PKA phosphorylation site in the 
C-terminal domain described by Uyeda and co-workers 
[6,10]. The sequence of the other labelled peptide was 
483-XVGSRPL-489. From the published amino acid 
sequence, X corresponds to Ser-483 and lies in a favour- 
able consensus equence (RNYS-483) for phosphoryla- 
tion by PKA [16]. Both Ser-466 and Ser-483 are located 
in the C-terminal peptide, which is deleted from the 
sequence of the 54,000 A!, form of bovine heart PFK-2/ 
FBPase-2. Since, the 54,000 M, form was 
phosphorylated by PKA, albeit with low stoichiometry, 
another phosphorylation site for PKA should exist out- 
side the C-terminal peptide containing Ser-466 and Ser- 
483 [7]. Ser-29 is a potential phosphorylation site for 
PKA, since it is Banked on its N-terminal side by two 
basic lysine residues, however, a synthetic peptide con- 
taining Ser-29 was a poor substrate for PKA (Table II). 
The fact that Ser-29 is a poor substrate might be ex- 
plained by the presence of the bulky C-adjacent rypto- 
phan residue. 
Bovine heart PFK-2/FBPase-2 is a multi-site 
phosphorylated enzyme (Fig. 2). PKC phosphorylates 
Thr-475 and Ser-84, whereas PICA phosphorylates Ser- 
466 and Ser-483. The interactions between the phospho- 
rylation sites are currently being studied. 
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